Patents by Inventor Dennis Delap

Dennis Delap has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Erodible embolization material for targeted tumor cryoablation
    Patent number: 8906003
    Abstract: A method of cryoablating diseased tissue is provided. The method includes providing an embolization agent. The embolization agent includes an inner core made of a first material. The inner core has a diameter less than a diameter of an opening of a target vessel. The embolization agent further includes an erodible outer shell made of a second embolization material encompassing the inner core. The erodible outer shell has an initial diameter greater than the diameter of the opening to occlude the target vessel. The method further includes occluding the opening of the target vessel with the embolization agent to reduce blood flow in the diseased tissue. The method further includes cryoablating the diseased tissue with a cryoablation probe while the target vessel is occluded by the embolization agent.
    Type: Grant
    Filed: June 5, 2012
    Date of Patent: December 9, 2014
    Assignee: Cook Medical Technologies LLC
    Inventor: Dennis Delap
  • ERODIBLE EMBOLIZATION MATERIAL FOR TARGETED TUMOR CRYOABLATION
    Publication number: 20130324988
    Abstract: A method of cryoablating diseased tissue is provided. The method includes providing an embolization agent. The embolization agent includes an inner core made of a first material. The inner core has a diameter less than a diameter of an opening of a target vessel. The embolization agent further includes an erodible outer shell made of a second embolization material encompassing the inner core. The erodible outer shell has an initial diameter greater than the diameter of the opening to occlude the target vessel. The method further includes occluding the opening of the target vessel with the embolization agent to reduce blood flow in the diseased tissue. The method further includes cryoablating the diseased tissue with a cryoablation probe while the target vessel is occluded by the embolization agent.
    Type: Application
    Filed: June 5, 2012
    Publication date: December 5, 2013
    Applicant: COOK MEDICAL TECHNOLOGIES LLC
    Inventor: Dennis Delap